Breaking the Camel's Back: Multicenter Clinical Trials and Local Institutional Review Boards
- 16 January 2001
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 134 (2) , 152-157
- https://doi.org/10.7326/0003-4819-134-2-200101160-00016
Abstract
Clinical research has undergone remarkable and beneficial expansion in the past 25 years, but with this growth has come an unprecedented increase in workload for the human subjects protection system. Recently, a major change in federal oversight of local institutional review boards (IRBs) became evident. Although it was not announced publicly, in 1998 and 1999 federal regulatory actions against local IRBs increased threefold. Particularly notable was the marked increase in regulatory actions taken against the IRBs of academic medical centers (1 in 1997 compared with 14 in 1999). Ironically, this apparent federal crackdown began at the same time that two federal review panels called for major changes in the regulations governing local IRBs. A key factor in the current crisis in the function of local IRBs is the ascendance of multicenter clinical trials as the dominant form of clinical research. Local IRBs were not designed to handle the initial evaluation and ongoing review required by the rapidly increasing number of multicenter clinical trials. Furthermore, local IRB review of the thousands of safety reports from multicenter clinical trials monopolizes resources without promoting patient safety. Instead of rigid enforcement of outmoded regulations that do not contribute to patient safety, the responsibilities of the local IRB in the oversight of multicenter clinical trials must be systematically evaluated.Keywords
This publication has 26 references indexed in Scilit:
- Dying for a CureAustralasian Psychiatry, 2008
- Performance of research ethics committees in Spain. A prospective study of 100 applications for clinical trial protocols on medicines.Journal of Medical Ethics, 1999
- Are ethics committees retarding the improvement of health services in Australia?The Medical Journal of Australia, 1999
- Remedies for Human Subjects of Cold War Research: Recommendations of the Advisory CommitteePublished by Cambridge University Press (CUP) ,1996
- The Data and Safety Monitoring Board and Acquired immune deficiency syndrome (AIDS) clinical trialsControlled Clinical Trials, 1995
- Ethics approval for a national postal survey: recent experienceBMJ, 1995
- The NHLBI model: A 25 year historyStatistics in Medicine, 1993
- Data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerationsStatistics in Medicine, 1993
- Institutional Review Board (IRB) Review Lacks Impact on the Readability of Consent Forms for ResearchThe Lancet Healthy Longevity, 1992
- The Tuskegee Syphilis StudyNew England Journal of Medicine, 1973